Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-08-20 08:20 am Sale | 13D | Oncology Institute Inc. TOI | Havencrest Healthcare Partners L.P. | 252,626 0.330% | -8,629,197 (-97.16%) | View |
| 2024-01-02 5:06 pm Sale | 13D | Oncology Institute Inc. TOI | Havencrest Healthcare Partners L.P. | 8,881,823 12.040% | -5,014,652 (-36.09%) | View |
| 2022-11-07 5:02 pm Sale | 13D | Oncology Institute Inc. TOI | Havencrest Healthcare Partners L.P. | 13,896,475 18.900% | -817,440 (-5.56%) | View |
| 2022-09-20 6:54 pm Sale | 13D | Oncology Institute Inc. TOI | Havencrest Healthcare Partners L.P. | 14,713,915 20.000% | -948,879 (-6.06%) | View |
| 2022-07-11 4:01 pm Unchanged | 13D | Oncology Institute Inc. TOI | Havencrest Healthcare Partners L.P. | 15,662,794 21.000% | 0 (Unchanged) | View |
| 2021-11-22 4:25 pm Purchase | 13D | Oncology Institute Inc. TOI | Havencrest Healthcare Partners L.P. | 15,662,794 21.000% | 15,662,794 (New Position) | View |